Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 10, 2026Japanese Journal of Clinical OncologyOpen Access

Splicing modulation as an emerging therapeutic strategy in cancer: molecular mechanisms, clinical development, and future perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

XJXinbate JingeleXi'an Jiaotong UniversityQSQinxinru SunNational Cancer Centre JapanXLXiaoyang LiNational Cancer Centre Japan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jingele et al. (2026) studied this question.

synapsesocial.com/papers/6aa3634a229fb590e7c60d7ehttps://doi.org/10.1093/jjco/hyag140
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer2014 · 2,751 citations
  2. 2Targeting RNA splicing modulation: new perspectives for anticancer strategy?2025 · 49 citations
  3. 3Spliceosome inhibition induces Z-RNA and ZBP1-driven cell death in small cell lung cancer2025 · 11 citations
  4. 4Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancer2024 · 13 citations